Knollwood Investment Advisory’s Idexx Laboratories IDXX Stock Holding History

Knollwood Investment Advisory’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.05M	Hold	5,800	–	–	0.27%	78
2026 Q1	$3.26M	Hold	5,800	–	–	0.33%	71
2025 Q4	$3.92M	Hold	5,800	–	–	0.37%	60
2025 Q3	$3.71M	Hold	5,800	–	–	0.33%	67
2025 Q2	$3.11M	Hold	5,800	–	–	0.3%	80
2025 Q1	$2.44M	Hold	5,800	–	–	0.27%	97
2024 Q4	$2.4M	Hold	5,800	–	–	0.25%	101
2024 Q3	$2.93M	Hold	5,800	–	–	0.31%	80
2024 Q2	$2.83M	Buy	5,800 +4,900	+544%	+$2.46M	0.31%	76
2024 Q1	$486K	Hold	900	–	–	0.09%	147
2023 Q4	$500K	Buy	+900	New	+$423K	0.1%	141

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Knollwood Investment Advisory's IDXX Position: Q2 2026 in Review

Knollwood Investment Advisory held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 5,800 shares worth $3.05M. The position accounts for 0.27% of the portfolio, ranked #78.

Knollwood Investment Advisory first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.92M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Knollwood Investment Advisory held 5,800 shares of Idexx Laboratories worth $3.05M as of Q2 2026.
Knollwood Investment Advisory left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.27% of Knollwood Investment Advisory's portfolio in Q2 2026, its #78 holding.
Knollwood Investment Advisory first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
Knollwood Investment Advisory's Idexx Laboratories position peaked at $3.92M in Q4 2025.
1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Knollwood Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.